Teresa Palmer to tackle producing duties for pharmaceutical project; already working on documentary
It seems that actress Teresa Palmer has been everywhere recently, appearing in mainstream films like BEDTIME STORIES, I AM NUMBER FOUR, and THE SORCERER’S APPRENTICE. She’s far and away been the greatest thing about most all of her projects, and now it looks like she’ll be taking even more control of where her career goes from here.
In an interview with Australian Vogue (via The Playlist), Palmer reveals that she’s interested in producing a script that focuses on the pharmaceutical industry and the corrupt practices within it; she also wants to lead the project. The actress will soon meet with DreamWorks about the film, which was once set to be a little indie flick.
Alongside the Happy Africa charity, Palmer is also producing a documentary in Kenya about happiness. Here’s a little bit more about that project, straight from Palmer:
“We are just going to let the kids run the documentary. We want them to talk to us about what makes them happy – just a study on why so many people from third-world countries seem to be able to find the happiness that is missing in a lot of people’s lives in more privileged countries like America and Australia.”
I knew there was something special about the actress when she appeared in THE SORCERER’S APPRENTICE, which was an otherwise drab affair. Palmer's interest in taking on multiple duties in the world of film is inspiring, and both of these projects sound extremely promising. I can’t wait to see what happens.
Commenting Rules: Comments are intended to open up the discussion to our readers about the topics at hand, and as such should be offered with a positive and constructive attitude. If your comment is not relative to the above post or is disrespectful to the authors and readers, we reserve the right to delete it. Continued abuse of our good nature will result in banishment of the offender. Additionally, if you have any burning issues to point out to the GATW crew - typos, corrections, suggestions, or straight-up criticism - please email us instead of commenting here.